Promising target for new pancreatic cancer treatments discovered

For almost three decades, scientists and physicians have known that a gene called the KRAS oncogene is mutated in virtually all pancreatic cancers, making it an important target for scientists looking for a way to stop the growth of pancreatic cancer tumors. Medical researchers have now narrowed the focus of this scientific quest to a protein called RGL2.

Read the whole article on Science Daily

More from Science Daily